4//SEC Filing
Feeley Kevin 4
Accession 0001944119-25-000021
CIK 0001818331other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:20 PM ET
Size
27.7 KB
Accession
0001944119-25-000021
Insider Transaction Report
Form 4
Feeley Kevin
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Class A Common Stock
2025-12-16+7,197→ 12,586 total - Sale
Class A Common Stock
2025-12-16$138.93/sh−131$18,200→ 12,455 total - Sale
Class A Common Stock
2025-12-16$140.08/sh−366$51,270→ 12,089 total - Sale
Class A Common Stock
2025-12-16$141.20/sh−951$134,286→ 11,138 total - Sale
Class A Common Stock
2025-12-16$142.12/sh−215$30,556→ 10,923 total - Sale
Class A Common Stock
2025-12-16$144.27/sh−334$48,187→ 10,589 total - Sale
Class A Common Stock
2025-12-16$145.36/sh−578$84,016→ 10,011 total - Sale
Class A Common Stock
2025-12-16$146.93/sh−699$102,703→ 9,312 total - Sale
Class A Common Stock
2025-12-16$148.55/sh−331$49,170→ 8,981 total - Sale
Class A Common Stock
2025-12-16$149.20/sh−97$14,472→ 8,884 total - Sale
Class A Common Stock
2025-12-16$150.75/sh−26$3,920→ 8,858 total - Sale
Class A Common Stock
2025-12-16$140.45/sh−127$17,837→ 8,731 total - Exercise/Conversion
Restricted Stock Unit
2025-12-16−7,197→ 35,984 total→ Class A Common Stock (7,197 underlying)
Footnotes (13)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.85 to $148.76, inclusive.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.01 to $149.32, inclusive.
- [F12]Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 8,731 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 113,504 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
- [F13]6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 16, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.65 to $139.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 11.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.70 to $140.465, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.72 to $141.68, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.76 to $142.41, inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.75 to $144.74, inclusive.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.80 to $145.55, inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.605 to $147.51, inclusive.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
Related Parties
1- filerCIK 0001944119
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:20 PM ET
- Size
- 27.7 KB